Pfizer Inc. said it made a final offer for AstraZeneca PLC valued at about $120 billion, after the British pharmaceutical company rebuffed its latest effort to enter takeover talks.

"They can either accept it or reject it," Pfizer Chairman and Chief Executive Ian Read said Sunday in an interview. "They have until the 26th of May" under British takeover rules.

New York-based Pfizer said its new offer...